Balaji Amines' Growth Roadmap | Ram Reddy, MD, Balaji Amines | Business and Market | ET Now News
What could be the revenue upside on account of new capex? Revenue guidance on a consolidated basis for Rs 2,500 crore for FY23 seems a bit conservative as Balaji Amines will be adding significant capacities. What maybe the reason for this cautious guidance? How is the trend in terms of the spreads and the EBITDA per kg? Because of the lockdown in China, Balaji Amines has seen abnormal gains (revenues). Is this expected to continue going ahead? What is the roadmap ahead? Speaking to ET Now, Ram Reddy, MD, Balaji Amines shares the details. Watch the full interview to find out more only on ET NOW.
#BalajiAminesStocks #BusinessMarketNews #ETNow
Subscribe To ET Now For Latest Updates On Stocks, Business, Trading | ► [ Ссылка ]
Subscribe Now To Our Network Channels :-
Times Now : [ Ссылка ]
The NewsHour Debate : [ Ссылка ]
To Stay Updated Download the Times Now App :-
Android Google Play : [ Ссылка ]
Apple App Store : [ Ссылка ]
Social Media Links :-
Twitter - [ Ссылка ]
Facebook - [ Ссылка ]
G+ - [ Ссылка ]
Website - www.etnownews.com
